The global consumption of psychiatric medication is increasing by 4% annually, with the greatest increase observed in ...

AbbVie said on Monday that an experimental schizophrenia drug it gained through an $8.7 billion deal for Cerevel Therapeutics failed two mid-stage studies, sending the drugmaker's shares plunging 12.5 ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Experts made the discovery after analysing hours of YouTube footage of celebrities with the disease - and it paves the way ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

Medically reviewed by Mary Choy, PharmDJoint pain can be caused by a number of biological, psychological, and social factors.

Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia ... and the ...

Favorable capital market conditions last week enabled the company to raise over $15 million from secondary offerings, and the proceeds allow the Company to fund fully the costs of this upcoming ...